About Source BioScience
Source BioScience is a Healthcare company based in Nottingham (United Kingdom) founded in 1903, and was acquired by Qualitas Funds in December 2023. Multiple genomic services are provided for analysis and diagnostics. Source BioScience has completed 3 acquisitions, including Camclinlabs, ImaGenes and Vindon. Its chief executive, as recorded, is Jay LeCoque. Its website sourcebioscience.com draws about 10 thousand monthly visits. Source BioScience offers products and services including Whole Genome Sequencing, Molecular Diagnostics, Histopathology Services, Nanopore Sequencing, and Sanger Sequencing. Its focus areas include Life Sciences, Genomics, Diversified and Life Sciences Platforms and Tools. Its legal entity is SOURCE BIOSCIENCE LIMITED.
Company details
Source BioScience was founded in 1903 in Nottingham, United Kingdom. Operations focus on the genomics sector, where genetic analysis and clinical diagnostics for research are conducted. Genome analysis, controlled environment storage, proteomics, drug discovery, and analytical testing are included in the services. Antibodies, assays, kits, and reagents are supplied, alongside reference laboratory testing for cancer and other diseases.
- Headquarters Nottingham, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website sourcebioscience.com
- Social LinkedIn X Facebook YouTube
- Acquired by Qualitas Funds (Dec 2023)
- Legal Name Source Bioscience Limited
- Date of Incorporation 14 Nov, 1903
- Jurisdiction NOTTINGHAM, NOTTINGHAMSHIRE
- Latest Funding Round$41.38M (USD), Post-IPO
Oct 2020
- InvestorsQualitas Funds
& 1 more
- Investments & AcquisitionsCamclinlabs
& 2 more
- Acquired byQualitas Funds
(Dec 2023)
Products & Services of Source BioScience
Source BioScience offers a comprehensive portfolio of products and services, including Whole Genome Sequencing, Molecular Diagnostics, Histopathology Services, Nanopore Sequencing, and Sanger Sequencing.
Service for sequencing entire genomes in research and clinical trials.
Tests for identifying genetic indications in healthcare settings.
Laboratory analysis for tissue samples in medical diagnostics.
Rapid sequencing method for DNA and RNA applications.
Traditional method for accurate DNA sequencing tasks.
Apps and channels of Source BioScience
its YouTube channel Source BioScience has 53 subscribers and 28 videos.
Videos from Source BioScience
The most watched videos on Source BioScience's YouTube channel, Source BioScience (53 subscribers). Click a video to play it here.
More on Source BioScience.
Funding Insights of Source BioScience
- Total Rounds 2
- Last Round Post-IPO — $41.38M
- Investors Count 1
All 2 funding rounds of Source BioScience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct 2020 | $41.38M | Post-IPO | – | – | – |
| Sep 2016 | Post-IPO | – | – |
2 investors in total: 2 institutional.
Investors in Source BioScience
Source BioScience has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Qualitas Funds and Harwood Private Equity.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Harwood Private Equity is focused on UK mid-market investments. | 1999 | harwoodpe.co.uk | London, United Kingdom | |
Fund of funds focused on lower mid-market investments | 2015 | qualitasfunds.com | Madrid, Spain |
Investor details for Source BioScience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Source BioScience
13 people are tracked at Source BioScience (5 in leadership, 8 in team).
| Name | Role | Group |
|---|---|---|
Jay LeCoque | CEO | Leadership |
Klaudyna Johnstone | Commercial Director | Leadership |
Richard Chaplin | IT Director | Leadership |
Amanda Barlow | Finance Director | Leadership |
Ian Ellis | Medical Director | Leadership |
Lucy Astill | Market Development Manager | Team |
Sbs Marketing | Marketing | Team |
Samantha Dewey Business Development Manager | Passionate Business Development Manager | Team |
Jacob Smith | Inside Sales Account Manager | Team |
Monica Devonshire | Customer Success Manager | Team |
Leisha Hankin | Marketing Manager | Team |
Oliver Swope | Technical Sales Specialist | Team |
Jade Erwin | Digital Integration Manager | Team |
Complete people profiles for Source BioScience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Source BioScience
Source BioScience has strategically engaged in corporate development activities, having acquired 3 companies. Notable acquisitions include Camclinlabs, ImaGenes and Vindon.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Personalized healthcare testing services in oncology and virology are provided. | camclinlabs.co.uk | United Kingdom | 0 | Apr 2025 | •••• | |
| vindon.co.uk | United Kingdom | 0 | Aug 2013 | $18.73M | ||
Genome research services, including gene cloning and profiling, are provided. | imagenes-bio.de | Berlin, Germany | 2007 | Dec 2010 | $3.11M |
Complete acquisition details for Source BioScience
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Source BioScience
8 dated milestones of Source BioScience across 122 years, from founding to its latest funding, stage changes and deals.
- Founded Source BioScience is founded.
- Acquisition Acquires ImaGenes.
- Acquisition Acquires Vindon.
- Funding First funding round.
- Funding Latest funding round, Post-IPO, of $41.4M.
- IPO Lists on the stock exchange (IPO).
- Exit Acquired by Qualitas Funds.
- Acquisition Acquires Camclinlabs.
Web traffic of Source BioScience
The website of Source BioScience (sourcebioscience.com) receives about 10.5K visits a month.
- Monthly visits10.5K
▼ 1.8% vs previous month
Websites whose visitors overlap most with Source BioScience. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
actionbioscience.org | actionbioscience.org | 100% | – | ||
| twistbioscience.com | 81% | 167.6K | #226,348 | View details | |
| etonbio.com | 81% | 15.4K | #1,163,824 | View details | |
eurofinsgenomics.eu | eurofinsgenomics.eu | 78% | – | ||
| sanger.ac.uk | 78% | 257.8K | #169,901 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 12 similar websites and full traffic analytics for Source BioScience
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 12 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
2 companies that operate in the same segment as Source BioScience (Genomics & Gene Therapy Platforms) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Source Bioscience
Complete news archive for Source BioScience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Source BioScience
Source BioScience was founded in 1903 and raised its 1st funding round 113 years after it was founded.
Source BioScience is headquartered in Nottingham, United Kingdom.
Jay LeCoque is the CEO of Source BioScience, as recorded in our data.
Source BioScience was founded in 1903 in Nottingham, United Kingdom. Operations focus on the genomics sector, where genetic analysis and clinical diagnostics for research are conducted. Genome analysis, controlled environment storage, proteomics, drug discovery, and analytical testing are included in the services. Antibodies, assays, kits, and reagents are supplied, alongside reference laboratory testing for cancer and other diseases.
Source BioScience offers Whole Genome Sequencing, Molecular Diagnostics, Histopathology Services, Nanopore Sequencing, and Sanger Sequencing.
Source BioScience has made 3 acquisitions, including Camclinlabs, ImaGenes, and Vindon.
Source BioScience has 2 investors. Key investors include Qualitas Funds, and Harwood Private Equity.
Source BioScience operates through Source Bioscience Limited.
Yes. Source BioScience was acquired by Qualitas Funds in December 2023.